GSK fires China research head over ‘misrepresented’ data

A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company resultsLONDON (Reuters) – British drugmaker GlaxoSmithKline has fired its head of research and development in China after discovering that a study by some of its Chinese scientists contained misrepresentation of data. A company spokesman said on Tuesday that Jiangwu Zang had been dismissed and three other individuals had been placed on administrative leave, while a further employee had resigned. The decision follows an investigation into concerns about a scientific paper published in the journal Nature Medicine in 2010 involving pre-clinical research into multiple sclerosis. …